Cargando…
Why was GOG-0213 a negative trial?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767651/ https://www.ncbi.nlm.nih.gov/pubmed/33300314 http://dx.doi.org/10.3802/jgo.2021.32.e19 |
| _version_ | 1783629006135885824 |
|---|---|
| author | Ehmann, Sarah Zivanovic, Oliver Chi, Dennis S. |
| author_facet | Ehmann, Sarah Zivanovic, Oliver Chi, Dennis S. |
| author_sort | Ehmann, Sarah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7767651 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77676512021-01-05 Why was GOG-0213 a negative trial? Ehmann, Sarah Zivanovic, Oliver Chi, Dennis S. J Gynecol Oncol Expert Opinion Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020-12-02 /pmc/articles/PMC7767651/ /pubmed/33300314 http://dx.doi.org/10.3802/jgo.2021.32.e19 Text en Copyright © 2021. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Expert Opinion Ehmann, Sarah Zivanovic, Oliver Chi, Dennis S. Why was GOG-0213 a negative trial? |
| title | Why was GOG-0213 a negative trial? |
| title_full | Why was GOG-0213 a negative trial? |
| title_fullStr | Why was GOG-0213 a negative trial? |
| title_full_unstemmed | Why was GOG-0213 a negative trial? |
| title_short | Why was GOG-0213 a negative trial? |
| title_sort | why was gog-0213 a negative trial? |
| topic | Expert Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767651/ https://www.ncbi.nlm.nih.gov/pubmed/33300314 http://dx.doi.org/10.3802/jgo.2021.32.e19 |
| work_keys_str_mv | AT ehmannsarah whywasgog0213anegativetrial AT zivanovicoliver whywasgog0213anegativetrial AT chidenniss whywasgog0213anegativetrial |